IceCure Medical Closes $10 Million Over-Subscribed Rights Offering

SEC Filing 6-K (0001213900-25-070605)

IceCure Medical Ltd. closed its rights offering on August 1, 2025, issuing 9,954,756 ordinary shares, warrants for 9,999,994 shares, and 45,238 pre-funded warrants. The offering generated $10 million in gross proceeds, approximately twice the initial subscription target. Proceeds will primarily repay a bridge loan from Epoch Partner Investments and fund general corporate operations. The offering saw strong investor participation, with 4.6 million additional shares issued via over-subscription privileges. Filed via Form 6-K, this event follows an SEC-effective Registration Statement (Form F-1) and includes forward-looking statements about capital allocation. Unexercised subscription rights expired upon closing. A July 29 press release highlighted the offering's success and outlined share distribution timelines.